Onno van de Stolpe
CEO, Galapagos
Hans Schikan
Biotech entrepreneur, Board member, ChairVarious biotech companies & organisations
Martine van Vugt
Chief of Staff, Genmab
Tim Knotnerus
CEO, AgomAb Therapeutics N.V.
André van de Sande
Interim Executive, Business Coach, Board Member
Hans Preusting
CEO, Synerkine Pharma
Eric Claassen
Professor of Entrepreneurship in Life SciencesVrije Universiteit Athena Institute
Erik van den Berg
CEO, AM-PharmaCo-founder & Chairman, Lava Therapeutics
Andrej Michalík
European Patent Attorney, Partner De Clercq & Partners
Florence Verhoestraete
Partner, NautaDutilh
Peter Craddock
Counsel, NautaDutilh
Shelley Margetson
CEO, OCTIMET Oncology NV
Wim Van Camp
General Manager Technology Transfer Ghent University
Tom Liessens
Legal Counsel, Trademark and Design AttorneyDe Clercq & Partners
Dr. Ann De Clercq
Founding Partner & European and Belgian Patent Attorney De Clercq & Partners
Rob Kieboom
Director, Rob Kieboom Training & Consultancy
Eline van Beest-Vrijland
Venture Partner Thuja Capital & Partner Blue Sparrows MedTech Fund & CEO, Hybridize Therapeutics
Jan Kooiman
Adj. Professor of Finance, Business and Accounting, Leiden University
Andre Hoekema
CBO, Galapagos
Simone Botti
Junior Partner, INKEF Capital B.V.
Powered by: Hyphen Projects | Connect with us | Join TAP BioBusiness | |||
Privacy Policy Terms & Conditions Chamber of Commerce: 75874415 | | Register |
© Copyright 2020 by Hyphen Projects |